In this study, we established a prognostic risk model for HCC with strong predictive performance. Risk-based stratification revealed its associations with immune infiltration, immunotherapy response, and drug sensitivity. These findings offer new insights into survival prediction and clinical features in patients with HCC.
Zhou et al. (Sun,) studied this question.